{"id":4920,"date":"2026-02-18T05:47:58","date_gmt":"2026-02-18T13:47:58","guid":{"rendered":"https:\/\/www.fziomed.com\/usa\/?p=4920"},"modified":"2026-02-18T05:47:59","modified_gmt":"2026-02-18T13:47:59","slug":"fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology","status":"publish","type":"post","link":"https:\/\/www.fziomed.com\/usa\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\/","title":{"rendered":"Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology"},"content":{"rendered":"\n<p><em>Fziomed\u2019s dual-polymer adhesion barrier technology platform is becoming a new standard of care as an adjunctive therapy.<\/em><\/p>\n\n\n\n<p><strong>SAN LUIS OBISPO, California, Feb. 18, 2026 \u2014 Fziomed, Inc.<\/strong>&nbsp;(\u201cFziomed\u201d or the \u201cCompany\u201d), a recognized global leader in postsurgical adhesion prevention with the best-in-class synthetic, absorbable gel technology platform, today announced that the Company has surpassed treating one million patients worldwide across its product portfolio over the past 20+ years.<\/p>\n\n\n\n<p>\u201cThis is a tremendous achievement for the Company and especially impactful for the patients who have benefitted from surgeons utilizing our adhesion barrier products across multiple specialties,\u201d said Jim Feeney, Vice President, International Sales. \u201cThis milestone provides convincing evidence of the long-standing safety and effectiveness of our adhesion barrier products over the past two decades in an ever-growing number of patients around the world, now including the United States.\u201d<\/p>\n\n\n\n<p>To commemorate the one millionth patient treated, Fziomed shared its appreciation with the physicians, nurses, and hospital staff who have supported numerous clinical studies over the years, as well as with the Company\u2019s global network of distributor partners and sales agents.<\/p>\n\n\n\n<p>\u201cWe are well on our way to establishing our unique adhesion barrier technology as a standard of care adjunctive therapy for nearly any surgical procedure,\u201d commented Paul Mraz, President and CEO. \u201cAs a vertically-integrated organization, I am incredibly proud of all our associates whose daily commitment to our company vision \u2013 helping patients \u2013 makes achievements like this possible.\u201d<\/p>\n\n\n\n<p>Fziomed\u2019s synthetic, clear, absorbable gels are based on the Company\u2019s proprietary dual-polymer technology platform, which provides a temporary, physical separation of tissues during the body\u2019s natural healing process. Clinical use of these products has been associated with improved patient outcomes, including reduced adhesion formation, improved fertility rates, decreased postoperative pain, and improved neurological symptoms. Fziomed\u2019s adhesion barrier products have been used clinically since 2002 and are marketed in more than seventy countries under various brand names.<\/p>\n\n\n\n<p>Fziomed will attend the 2026 Spine Summit, February 26 \u2013 March 1, in Phoenix, Arizona where the Company will showcase its Oxiplex Absorbable Gel for Spine Surgery. Visit Fziomed at Booth #205 to learn more.<\/p>\n\n\n\n<p><strong>About Fziomed, Inc.<\/strong><\/p>\n\n\n\n<p>Pioneering biomaterials since 1996, Fziomed is a recognized global leader in postsurgical adhesion prevention&nbsp;focused on addressing an unmet clinical need in spine, tendon, nerve, abdominal, pelvic, and intrauterine procedures.&nbsp;Fziomed develops, manufactures, and commercializes best-in-class surgical biomaterials used by clinicians to&nbsp;<em>Preserve Surgical Excellence<sup>SM<\/sup><\/em>and improve patient outcomes.<\/p>\n\n\n\n<p>Fziomed is headquartered in San Luis Obispo, California, and has been named one of the&nbsp;<em>Best Places to Work in Southern California<\/em>&nbsp;for the past three consecutive years.<\/p>\n\n\n\n<p>Visit\u00a0<a href=\"http:\/\/www.fziomed.com\/\">fziomed.com<\/a>\u00a0to learn more about Fziomed and our industry-leading products.<br><br><br><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Fziomed\u2019s dual-polymer adhesion barrier technology platform is becoming a new standard of care as an adjunctive therapy. SAN LUIS OBISPO, California, Feb. 18, 2026 \u2014 Fziomed, Inc.&nbsp;(\u201cFziomed\u201d or the \u201cCompany\u201d), a recognized global leader in postsurgical adhesion prevention with the best-in-class synthetic, absorbable gel technology platform, today announced that the Company has surpassed treating one [&hellip;]<\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[44],"tags":[],"class_list":["post-4920","post","type-post","status-publish","format-standard","hentry","category-news-releases","pmpro-has-access"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology - Fziomed USA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fziomed.com\/usa\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology - Fziomed USA\" \/>\n<meta property=\"og:description\" content=\"Fziomed\u2019s dual-polymer adhesion barrier technology platform is becoming a new standard of care as an adjunctive therapy. SAN LUIS OBISPO, California, Feb. 18, 2026 \u2014 Fziomed, Inc.&nbsp;(\u201cFziomed\u201d or the \u201cCompany\u201d), a recognized global leader in postsurgical adhesion prevention with the best-in-class synthetic, absorbable gel technology platform, today announced that the Company has surpassed treating one [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fziomed.com\/usa\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"Fziomed USA\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-18T13:47:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-18T13:47:59+00:00\" \/>\n<meta name=\"author\" content=\"Ryan Bledsoe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ryan Bledsoe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\\\/\"},\"author\":{\"name\":\"Ryan Bledsoe\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#\\\/schema\\\/person\\\/2154d83646a79bef9885ce67ea06a0a4\"},\"headline\":\"Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology\",\"datePublished\":\"2026-02-18T13:47:58+00:00\",\"dateModified\":\"2026-02-18T13:47:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\\\/\"},\"wordCount\":451,\"articleSection\":[\"News Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\\\/\",\"url\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\\\/\",\"name\":\"Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology - Fziomed USA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#website\"},\"datePublished\":\"2026-02-18T13:47:58+00:00\",\"dateModified\":\"2026-02-18T13:47:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#\\\/schema\\\/person\\\/2154d83646a79bef9885ce67ea06a0a4\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#website\",\"url\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/\",\"name\":\"Fziomed USA\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#\\\/schema\\\/person\\\/2154d83646a79bef9885ce67ea06a0a4\",\"name\":\"Ryan Bledsoe\",\"url\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/author\\\/rbledsoe\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology - Fziomed USA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fziomed.com\/usa\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\/","og_locale":"en_US","og_type":"article","og_title":"Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology - Fziomed USA","og_description":"Fziomed\u2019s dual-polymer adhesion barrier technology platform is becoming a new standard of care as an adjunctive therapy. SAN LUIS OBISPO, California, Feb. 18, 2026 \u2014 Fziomed, Inc.&nbsp;(\u201cFziomed\u201d or the \u201cCompany\u201d), a recognized global leader in postsurgical adhesion prevention with the best-in-class synthetic, absorbable gel technology platform, today announced that the Company has surpassed treating one [&hellip;]","og_url":"https:\/\/www.fziomed.com\/usa\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\/","og_site_name":"Fziomed USA","article_published_time":"2026-02-18T13:47:58+00:00","article_modified_time":"2026-02-18T13:47:59+00:00","author":"Ryan Bledsoe","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ryan Bledsoe","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fziomed.com\/usa\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\/#article","isPartOf":{"@id":"https:\/\/www.fziomed.com\/usa\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\/"},"author":{"name":"Ryan Bledsoe","@id":"https:\/\/www.fziomed.com\/usa\/#\/schema\/person\/2154d83646a79bef9885ce67ea06a0a4"},"headline":"Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology","datePublished":"2026-02-18T13:47:58+00:00","dateModified":"2026-02-18T13:47:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fziomed.com\/usa\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\/"},"wordCount":451,"articleSection":["News Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fziomed.com\/usa\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\/","url":"https:\/\/www.fziomed.com\/usa\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\/","name":"Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology - Fziomed USA","isPartOf":{"@id":"https:\/\/www.fziomed.com\/usa\/#website"},"datePublished":"2026-02-18T13:47:58+00:00","dateModified":"2026-02-18T13:47:59+00:00","author":{"@id":"https:\/\/www.fziomed.com\/usa\/#\/schema\/person\/2154d83646a79bef9885ce67ea06a0a4"},"breadcrumb":{"@id":"https:\/\/www.fziomed.com\/usa\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fziomed.com\/usa\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.fziomed.com\/usa\/fziomed-commemorates-one-millionth-patient-treated-with-its-dual-polymer-adhesion-barrier-technology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fziomed.com\/usa\/home\/"},{"@type":"ListItem","position":2,"name":"Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology"}]},{"@type":"WebSite","@id":"https:\/\/www.fziomed.com\/usa\/#website","url":"https:\/\/www.fziomed.com\/usa\/","name":"Fziomed USA","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fziomed.com\/usa\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.fziomed.com\/usa\/#\/schema\/person\/2154d83646a79bef9885ce67ea06a0a4","name":"Ryan Bledsoe","url":"https:\/\/www.fziomed.com\/usa\/author\/rbledsoe\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/posts\/4920","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/comments?post=4920"}],"version-history":[{"count":0,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/posts\/4920\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/media?parent=4920"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/categories?post=4920"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/tags?post=4920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}